Fundraising Fox

Healthtech Startups

17,201 companies tagged Healthtech, with their investors and founders.

GEN ONE CIG

0 investors

Genben Lifesciences

0 investors

Gencia

0 investors

Gene Sciences

0 investors

Geneius Biotechnology

Geneius develops and commercializes autologous adoptive T-cell therapies designed to treat cancer by targeting the mutations driving a patient's disease. The company aims to deliver its immunotherapy through community oncologists at a lower cost than CAR-T, in the oncology/immunotherapy space.

0 investors

GenEp

0 investors

General Fluidics

General Fluidics builds Axess, a point-of-care diagnostic analyzer powered by its patented Embedded Fluidics Systems that runs clinical chemistry, hematology, and immunoassay panels from a single cartridge in under 20 minutes. It targets decentralized healthcare settings such as doctors' offices and clinics, enabling reference-lab-quality blood test results during a single patient visit.

0 investors

General Prognostics

0 investors

Generic Investments

0 investors

Genesis Alternative Finance Holdings

0 investors

Genesis Healthcare

0 investors

Genesis Innovation Group

Genesis Innovation Group provides comprehensive medical device development services from ideation through commercialization, serving early-stage entrepreneurs and innovators with strategic guidance, technical expertise, and industry relationships.

0 investors

Genesis Software Innovations

0 investors

Geneva Healthcare

0 investors

Genoa Pharmaceuticals

Avalyn Pharma (formerly Genoa Pharmaceuticals) is a biopharma company developing inhaled therapies for idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. Its lead asset is inhaled pirfenidone (Aerodone), a nebulized reformulation designed to deliver effective lung levels while reducing the side effects of oral dosing.

0 investors

Genoa-QoL Investment Holdings

0 investors

Genome Medical Holding Co

0 investors

Genomedx Biosciences

0 investors

Genomic Life

0 investors

Genprex

Genprex is a clinical-stage gene therapy company developing treatments for cancer and diabetes, including approaches that reintroduce tumor suppressor genes and stabilize glucose levels. Its therapies have received multiple FDA Fast Track Designations and are being evaluated in clinical trials.

0 investors

GenrAb

GenrAb develops neuroprotective therapies derived from the human immune system to treat neurological diseases including ALS, Parkinson's, Alzheimer's, and Multiple Sclerosis. The company addresses unmet needs in neurodegeneration treatment by harnessing immunological pathways to prevent disease progression.

0 investors

Gentle Scan Health

0 investors

Georgia Dental

Georgia Dental Group operates dental clinics offering comprehensive oral health care, including cosmetic, emergency, periodontics, general, family, restorative, and implant dentistry for patients of all ages. It serves communities in Eastman, Fitzgerald, and LaGrange, Georgia across six locations.

0 investors

Georgia Proton Treatment Center

0 investors

Other sectors & tags